Clinical Trial Update: Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating a combination of docetaxel, oxaliplatin, and fluorouracil in patients with metastatic or unresectable stomach/gastroesophageal juncti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer
• Unspecified Adult Solid Tumor

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• FLUOROURACIL (Fluorouracil)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Northwestern University | Conditions: Gastric Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-10-26